Copy to clipboard 
Kapstone Manufacturing, a division of Kapstone Medical, will become the first U.S.-based medical device CDMO+ to integrate the DLyte 100Pro dry electropolishing system in-house. The system arrives at Kapstone’s ISO 13485-certified Charlotte facility in Q3 2026 and will operate alongside the company’s metal additive manufacturing line.
For customers running metal AM medical device programs — orthopedic implants, dental, surgical instrumentation — the addition removes an outbound finishing step that has historically slowed the AM-to-finish workflow. Printed parts no longer leave the building to reach a sub-0.2 μm Ra surgical finish. One quality system, single-source from print to qualified part.
“Our customers don’t ask for a finishing supplier — they ask for finished parts,” said John Kapitan, CEO of Kapstone Medical. “Bringing DLyte in-house removes a hand-off that’s been costing AM medical device programs weeks of turnaround and an extra supplier qualification. From prototype through commercial build and distribution, the part stays under our QMS.”
“Partnering with Kapstone allows us to show the true power of automation in medical manufacturing,” said Jesús Contreras, Managing Director of GPAINNOVA America. “The DLyte 100Pro ensures repeatable, surgical-grade surface finishes for complex geometries, giving their customers a faster, fully compliant route to market under a single CDMO.”
The DLyte 100Pro processes up to 8 kg (17.6 lb) per cycle across stainless steel, cobalt-chrome, titanium, Nitinol, copper, nickel, and aluminum alloys. The patented DryLyte® process uses ion transport through solid media — no liquid baths, non-abrasive — and reaches lattice structures and internal geometries that traditional electropolishing cannot.
The DLyte 100Pro will be on display at the DLyte booth at OMTEC 2026, June 9–11, at the Donald E. Stephens Convention Center in Rosemont, IL.
Source: Kapstone Manufacturing
